What is Nuliv Science?
NuLiv Science operates as a global leader in the development and distribution of research-backed nutraceutical solutions. The company specializes in a diverse portfolio of natural ingredients designed to enhance bioavailability and absorption, catering to critical health segments including sports nutrition, weight management, glucose balance, bone health, and cognitive performance. Its branded ingredient line, which features industry-standard products such as AstraGin, InnoSlim, and ActiGin, serves as the backbone of its market authority. By prioritizing clinical validation and time-tested efficacy, NuLiv Science provides essential components for wellness brands worldwide, effectively bridging the gap between raw natural resources and high-performance health applications.
How much funding has Nuliv Science raised?
Nuliv Science has raised a total of $337K across 2 funding rounds:
Debt
$150K
Debt
$187K
Debt (2020): $150K with participation from PPP
Debt (2021): $187K led by PPP
Key Investors in Nuliv Science
PPP
Public-Private Partnership
What's next for Nuliv Science?
With the successful acquisition of this latest capital, NuLiv Science is poised to enter a new phase of scaling and market penetration. The strategic focus will likely shift toward deepening its research capabilities and expanding the global distribution of its flagship ingredients. As the demand for transparent, science-driven wellness products continues to rise, the company is strategically aligned to capture additional market share. Future initiatives will likely involve the optimization of supply chain efficiencies and the potential development of next-generation nootropics and metabolic health solutions, ensuring that NuLiv Science remains a pivotal partner for health-conscious consumers and manufacturers alike.
See full Nuliv Science company page
